AVASCULAR NECROSIS AS A MANIFESTATION OF POST-COVID SYNDROME IN ROUTINE PRACTICE OF RHEUMATOLOGIST-Reference-Cited by-同舟云学术

AVASCULAR NECROSIS AS A MANIFESTATION OF POST-COVID SYNDROME IN ROUTINE PRACTICE OF RHEUMATOLOGIST

Published:2023-05-05 Issue:5 Volume:34 Page:43-47
ISSN:2587-7305
Container-title:Vrach
language:
Short-container-title:Vrach

Author:

Bazina I.¹,Krechikova D.²,Kozyrev O.¹,Pavlova M.¹,Loginova I.¹,Kononova V.¹,Yakub L.¹

Affiliation:

1. Smolensk State Medical University

2. Clinical hospital «RZhD-Medicine», Smolensk

Abstract

Avascular necrosis as a part of post-COVID syndrome requires increased attention of physicians due to significant misfunction of musculoskeletal system, increased disability, and frequently requires surgical intervention. It is known that hypercoagulation, thrombosis as well as systemic corticosteroid therapy during severe coronavirus infection play an important role in the development of avascular necrosis. A case report of progressive avascular necrosis in multiple loci accompanied by polyarthritis in a young man developed after severe COVID-19 is reported below

Publisher

Russian Vrach, Publishing House Ltd.

Reference14 articles.

1. Насонов Е.Л., Лила А.М., Мазуров В.И. и др. Коронавирусная болезнь 2019 (COVID-19) и иммуновоспалительные ревматические заболевания. Рекомендации Общероссийской общественной организации «Ассоциация ревматологов России». Научно-практическая ревматология. 2021; 59 (3): 239–54 [Nasonov E.L., Lila A.M., Mazurov V.I. et al. Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia. Rheumatology Science and Practice. 2021; 59 (3): 239–54 (in Russ.)]. DOI: 10.47360/1995-4484-2021-239-254

2. Lopez-Leon S., Wegman-Ostrosky T., Perelman C. et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv. 2021; 2021.01.27.21250617 (Preprint). DOI: 10.1101/2021.01.27.21250617

3. Fan B.E., Umapathi T., Chua K. et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis. 2021; 51 (4): 971–7. DOI: 10.1007/s11239-020-02332-z

4. Zhang W., Zhao Y., Zhang F. et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. Clin Immunol. 2020; 214: 108393. DOI: 10.1016/j.clim.2020.108393

5. Zhang Y., Xiao M., Zhang S. et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020; 382 (17): e38. DOI: 10.1056/NEJMc2007575